Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2025 09:16 ET | Source: Research and Markets

Myelodysplastic Syndrome Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status

Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering.The clinical trial report...
December 24, 2024 05:01 ET | Source: Research and Markets

Myelodysplastic Syndrome (MDS) Drugs Market Trends and Sales Forecast to 2030: Total Revenues to Reach US$4.1 Billion Worldwide, with Immunomodulatory Drugs Dominating Shares

Dublin, Dec. 24, 2024 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
January 24, 2024 13:33 ET | Source: Research and Markets

Myelodysplastic Syndrome Drugs Market Report 2024-2033 with Analysis of Key Trends Including Erythropoiesis-Stimulating Agents Optimization, Combination Therapies Integration, Emphasis on Iron Chelation Therapy

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global myelodysplastic...
June 06, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Myelodysplastic Syndrome Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - AbbVie, Gilead Sciences, Novartis, AstraZeneca, Sanofi, Incyte, Celgene, Fibrogen, Precigen

New Year, USA, June 06, 2023 (GLOBE NEWSWIRE) -- Myelodysplastic Syndrome Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - AbbVie, Gilead Sciences, Novartis,...
October 12, 2021 20:00 ET | Source: DelveInsight Business Research LLP

DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape

Las Vegas, USA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndrome as Influential Pharma Players Set Foot in the MDS Landscape ...